Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Dopamine D2 Receptor ELISA Kit (AC3506)
Cat.#: ASET-2095
Specifications
Description Rat Dopamine D2 Receptor ELISA Kit allows for the in vitro quantitative determination of rat Dopamine D2 Receptor concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.938 mIU/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.563-100 mIU/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1018 Human GPRC5A ELISA Kit (AC2429) Quantitative inquiry ASET-1154 Human PEDF ELISA Kit (AC2565) Quantitative inquiry ASET-1848 Rat Notch2 ELISA Kit (AC3259) Quantitative inquiry ASET-1888 Human CLN3 ELISA Kit (AC3299) Quantitative inquiry ASET-1297 Rat Myelin Basic Protein ELISA Kit (AC2708) Quantitative inquiry ASET-2366 Human Wnt3a ELISA Kit (AC3777) Quantitative inquiry ASET-1232 Human NENF ELISA Kit (AC2643) Quantitative inquiry ASET-1740 Rabbit Myelin Basic Protein ELISA Kit (AC3151) Quantitative inquiry ASET-2134 Human Myotrophin ELISA Kit (AC3545) Quantitative inquiry ASET-2514 Human ABCA7 ELISA Kit (AC3925) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket